What is the concern about Singulair (montelukast)?
Singulair is a major drug in asthma treatment – it is important to review recent developments and put these findings in perspective of overall asthma care for individual patients.
Singulair (montelukast)
Singulair (manufactured and marketed by Merck and Co.) is a drug of the so-called anti-leukotriene class that is used for control of symptoms of asthma and allergic rhinitis (hay fever). It was initially approved by the U.S. Food and Drug...
Hi everybody! I hope you all have been having a pretty good week and hanging in there. Sometimes it is a measure of our success... Read more »
If you are suffering through the distress of an illness or its treatment, and your suffering has escalated to unmanageable levels, what do... Read more »
Over the last four or five weeks, we have been exploring the topic of happiness. It is fair to say that the guru on the topic is Martin... Read more »
A report published in The American Journal of Medicine (AJM) lends additional support to the discovery that people who receive bariatric... Read more »
Someone in chronic pain may need to see a psychologist because of the huge emotional toll. Depending on the situation, a person in pain may... Read more »
According to a Canadian study, teenagers who are insecure are more likely to suffer from chronic headaches, joint pain, and depression than their... Read more »
Studies have shown that stroke often leads to depression, but the evidence from those studies has been mixed as to whether depression could lead to... Read more »
Physicians have known for years that women who have more to term pregnancies appear to be somewhat protected against developing breast cancer. Women... Read more »
Boston scientists have found that people who have survived a bout with cancer are more likely than the general population to suffer psychological... Read more »
Japanese researchers have found that people who suffer from chronically itchy skin can also have a higher risk of developing anxiety, depression, and... Read more »